« previous next »
Pages: [1]

Author Topic: Tecfidera vs Gilenya, Rituxan vs Tysabri compared  (Read 38 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
Tecfidera vs Gilenya, Rituxan vs Tysabri compared
« on: November 20, 2021, 09:43:09 pm »

From JAMA (November 16, 2021)--"Comparison of dimethyl fumarate vs fingolimod and rituximab vs natalizumab for treatment of multiple sclerosis":


https://bit.ly/3FBGAJU


Quote
Findings:  This comparative effectiveness study integrated electronic health records with research registry data and found no significant differences in relapse outcomes between dimethyl fumarate and fingolimod after correcting for confounding biases. Rituximab was associated with a lower relapse rate when compared with natalizumab after bias correction.
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
165 Views 		Last post June 08, 2018, 09:02:03 pm
by agate
0 Replies
145 Views 		Last post June 08, 2018, 09:06:06 pm
by agate
1 Replies
135 Views 		Last post October 12, 2018, 08:34:59 am
by agate
2 Replies
134 Views 		Last post October 17, 2019, 09:09:54 pm
by agate
0 Replies
59 Views 		Last post February 11, 2020, 08:05:28 pm
by agate